- Home
- SYRE vs PLAY Comparison
SYRE vs PLAY Comparison
Compare SYRE & PLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- PLAY
- Stock Information
- Founded
- SYRE 2013
- PLAY 1982
- Country
- SYRE United States
- PLAY United States
- Employees
- SYRE N/A
- PLAY N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- PLAY Restaurants
- Sector
- SYRE Health Care
- PLAY Consumer Discretionary
- Exchange
- SYRE Nasdaq
- PLAY Nasdaq
- Market Cap
- SYRE 1.1B
- PLAY 884.5M
- IPO Year
- SYRE 2016
- PLAY 1995
- Fundamental
- Price
- SYRE $17.38
- PLAY $25.34
- Analyst Decision
- SYRE Buy
- PLAY Hold
- Analyst Count
- SYRE 5
- PLAY 8
- Target Price
- SYRE $55.00
- PLAY $31.83
- AVG Volume (30 Days)
- SYRE 490.8K
- PLAY 756.3K
- Earning Date
- SYRE 08-05-2025
- PLAY 09-09-2025
- Dividend Yield
- SYRE N/A
- PLAY N/A
- EPS Growth
- SYRE N/A
- PLAY N/A
- EPS
- SYRE N/A
- PLAY 1.02
- Revenue
- SYRE N/A
- PLAY $2,112,300,000.00
- Revenue This Year
- SYRE N/A
- PLAY $4.00
- Revenue Next Year
- SYRE N/A
- PLAY $6.58
- P/E Ratio
- SYRE N/A
- PLAY $24.65
- Revenue Growth
- SYRE N/A
- PLAY N/A
- 52 Week Low
- SYRE $10.91
- PLAY $15.08
- 52 Week High
- SYRE $40.26
- PLAY $43.73
- Technical
- Relative Strength Index (RSI)
- SYRE 57.01
- PLAY 42.84
- Support Level
- SYRE $15.73
- PLAY $23.33
- Resistance Level
- SYRE $17.42
- PLAY $26.68
- Average True Range (ATR)
- SYRE 0.89
- PLAY 1.24
- MACD
- SYRE 0.07
- PLAY -0.08
- Stochastic Oscillator
- SYRE 86.50
- PLAY 42.86
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About PLAY Dave & Buster's Entertainment Inc.
Dave & Buster's Entertainment Inc owns and operates nearly a hundred entertainment and dining establishments in the United States where customers can eat, drink, play games, and watch televised sports. Each store offers a full menu of entries and appetizers, a complete selection of alcoholic and non-alcoholic beverages, and an extensive assortment of entertainment attractions centered around playing games and watching live sports and other televised events. It derives maximum revenue from Entertainment.